Cybin Inc. (CYBN)
NYSEAMERICAN: CYBN · Real-Time Price · USD
5.98
-0.09 (-1.48%)
Nov 7, 2025, 4:00 PM EST - Market closed
Cybin Market Cap
Cybin has a market cap or net worth of $165.2 million as of November 7, 2025. Its market cap has decreased by -24.43% in one year.
Market Cap
165.20M
Enterprise Value
91.01M
1-Year Change
-24.43%
Ranking
Category
Stock Price
$5.98
Market Cap Chart
Since November 11, 2020, Cybin's market cap has increased from $91.10M to $165.20M, an increase of 81.35%. That is a compound annual growth rate of 12.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 165.20M | -6.35% |
| Dec 31, 2024 | 176.41M | 4.62% |
| Dec 29, 2023 | 168.63M | 199.71% |
| Dec 30, 2022 | 56.26M | -72.57% |
| Dec 31, 2021 | 205.14M | 4.86% |
| Dec 31, 2020 | 195.64M | 114.76% |
| Nov 11, 2020 | 91.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 828.96B |
| Johnson & Johnson | 448.13B |
| AbbVie | 383.12B |
| UnitedHealth Group | 296.88B |
| AstraZeneca | 251.76B |
| Novartis AG | 240.29B |
| Abbott Laboratories | 216.56B |
| Thermo Fisher Scientific | 213.27B |